The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-((E)-(4-((E)-(2,4-diamino-5-methylphenyl)diazenyl)phenyl)diazenyl)-2-hydroxybenzoic acid ID: ALA1270266
Chembl Id: CHEMBL1270266
Cas Number: 739301-85-0
PubChem CID: 413222
Max Phase: Preclinical
Molecular Formula: C20H18N6O3
Molecular Weight: 390.40
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Synonyms: NSC-45586 | NSC45586|CHEMBL1270266|NSC-45586|739301-85-0|DTXSID801039270|BDBM50328826|5-((E)-(4-((E)-(2,4-diamino-5-methylphenyl)diazenyl)phenyl)diazenyl)-2-hydroxybenzoic acid|HY-19820|CS-0016846|5-((4-((2,4-Diamino-5-methylphenyl)diazenyl)phenyl)diazenyl)-2-hydroxybenzoic acid|Benzoic acid, 5-[2-[4-[2-(2,4-diamino-5-methylphenyl)diazenyl]phenyl]diazenyl]-2-hydroxy-
Canonical SMILES: Cc1cc(/N=N/c2ccc(/N=N/c3ccc(O)c(C(=O)O)c3)cc2)c(N)cc1N
Standard InChI: InChI=1S/C20H18N6O3/c1-11-8-18(17(22)10-16(11)21)26-24-13-4-2-12(3-5-13)23-25-14-6-7-19(27)15(9-14)20(28)29/h2-10,27H,21-22H2,1H3,(H,28,29)/b25-23+,26-24+
Standard InChI Key: LNPJMIMLAFXLSJ-OGGGYYITSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 390.40Molecular Weight (Monoisotopic): 390.1440AlogP: 5.39#Rotatable Bonds: 5Polar Surface Area: 159.01Molecular Species: ACIDHBA: 8HBD: 4#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 6#RO5 Violations (Lipinski): 2CX Acidic pKa: 3.54CX Basic pKa: 2.94CX LogP: 5.02CX LogD: 2.21Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.34Np Likeness Score: -0.29
References 1. Sierecki E, Sinko W, McCammon JA, Newton AC.. (2010) Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening., 53 (19): [PMID:20836557 ] [10.1021/jm100331d ]